Holland & Knight represented Conduent Incorporated, while Willkie Farr & Gallaher served as independent legal counsel to the Special Transaction Committee in the transaction. Conduent Incorporated...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher advised Resideo Technologies, Inc., while Simpson Thacher & Bartlett advised Snap One Holdings Corp., and Kirkland & Ellis advised Clayton, Dubilier &...
You must be a Standard 1 Year member to access this content.
White & Case LLP advised Xerox , Willkie Farr & Gallagher represented the Special Committee of the Board of Directors of Xerox Holdings Corporation, and Latham...
You must be a Standard 1 Year member to access this content.
Willkie recently represented Barry Sternlicht, Chairman and CEO of Starwood Capital Group, in his successful proxy contest at Cano Health, Inc. Cano Health announced the resignation...
You must be a Standard 1 Year member to access this content.
Willkie represented Carrix in the transaction. Carrix, a leading marine terminal operator in the U.S. and the Americas, announced on June 22 that it agreed to...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as the Special Committee’s legal counsel. Kirkland & Ellis advised Bain Capital and Diversey. Gibson, Dunn & Crutcher and Willkie...
You must be a Standard 1 Year member to access this content.
Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher advised Innoviva on the transaction. Innoviva, Inc., a diversified holding company with a portfolio of royalties and a growing portfolio of innovative...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher LLP represented Innoviva in the transaction, while Kirkland & Ellis advised GlaxoSmithKline. Innoviva, Inc. (NASDAQ: INVA) executed definitive agreement to purchase Glaxo...
You must be a Standard 1 Year member to access this content.
